A Real-World Analysis of the Clinical Journey, Diagnosis, and Monitoring Patterns of Patients With Alzheimer Disease by Stage in the United States
Prediction of infusion capacity to deliver Alzheimer’s disease treatments in the United States relative to expected demand
A preliminary economic evaluation of a potential program for the primary prevention of Alzheimer’s disease
Demographic and clinical characteristics of initial patients receiving amyloid-targeting treatments in the United States after regulatory approval
Effects of the Davos Alzheimer’s Collaborative early detection of cognitive impairment program on clinician attitudes, engagement, and confidence
Disparities in Access to Diagnostic Evaluation for Alzheimer’s Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study
American’s overall and equity-based societal valuation of a disease-modifying Alzheimer’s treatment: Results from a discrete choice experiment